NCT05606783

Brief Summary

Family Medicine patients with uncontrolled hypertension will be given a Bluetooth enabled home blood pressure machine to monitor their blood pressure every day for 6 weeks. The blood pressure results will be sent automatically to the patient's electronic medical record via applications on their iPhone. Study pharmacists will follow-up with the patients once per week via a telehealth appointment using the app VSee, where the blood pressure results will be reviewed. The pharmacists will also counsel the patients on lifestyle modifications in order to improve blood pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable hypertension

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 26, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
3.4 years until next milestone

First Posted

Study publicly available on registry

November 7, 2022

Completed
Last Updated

November 7, 2022

Status Verified

January 1, 2019

Enrollment Period

3 months

First QC Date

March 26, 2019

Last Update Submit

November 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comfort

    Patient comfort in using home telemonitoring for blood pressure combined with pharmacist counseling and monitoring will be measured using a survey instrument with a Likert scale (4-point scale). (Most of the time; Some of the time; Seldom; Never) (Strongly agree; Agree; Disagree; Strongly disagree) (Nothing; Very little; Some; Knowledgeable)

    8 weeks

Secondary Outcomes (1)

  • Determine if pharmacists' interventions improved BP

    8 weeks

Study Arms (1)

Home blood pressure monitoring

EXPERIMENTAL

* Smart Phones with Apple Health Software will be used to monitor blood pressure once a day, and results will be sent automatically to the patients EHR (Epic) * The Omron 10 Series Wireless Upper Arm Blood Pressure Device will be given to the patient to monitor blood pressure at home daily * Patients will be scheduled for a one-hour in-person appointment for the initial study visit where informed consent will be obtained, and for the final study visit

Behavioral: Telehealth Follow-up VisitsBehavioral: SurveysDevice: Devices

Interventions

• Follow-up with patients once per week for six (6) weeks via scheduled 20-minute telehealth appointment with each patient via the HIPAA secure and compliant platform, VSee o During this telehealth appointment, the study pharmacists will counsel the patients on their blood pressure readings for that week and provide lifestyle education focusing on patient-specific diet and exercise recommendations

Home blood pressure monitoring
SurveysBEHAVIORAL

A pre- and post-survey will be given at the initial and final in-person appointments, respectively • These surveys will collect basic patient demographics, knowledge of blood pressure, comfort with checking blood pressure at home, and previous experience working with a pharmacist

Home blood pressure monitoring
DevicesDEVICE

Smart Phones with Apple Health Software will be used to monitor blood pressure once a day, and results will be sent automatically to the patients EHR (Epic) • The Omron 10 Series Wireless Upper Arm Blood Pressure Device will be given to the patient to monitor blood pressure at home daily

Home blood pressure monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • must be at least 18 years old
  • have a smartphone compatible with the mobile intervention (iPhone)
  • have been previously diagnosed with hypertension
  • have uncontrolled hypertension (SBP \> 130 mmHg and/or DBP \> 80 mmHg)
  • be under the care of a primary care physician in the Family Medicine Department of the USF Morsani Center for Advanced Care
  • have had at least one prescription filled at Pharmacy Plus within the last six months
  • speaks English fluently

You may not qualify if:

  • already under the care of a clinical pharmacist in the Family Medicine department
  • pregnant
  • have a serious existing medical condition(s) that may affect their ability to self-monitor their blood pressure (for example, stroke, dementia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USF Pharmacy Plus

Tampa, Florida, 33612, United States

Location

MeSH Terms

Conditions

Hypertension

Interventions

Surveys and QuestionnairesEquipment and Supplies

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Wendy H Updike, PharmD

    University of South Florida College of Pharmacy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2019

First Posted

November 7, 2022

Study Start

January 23, 2019

Primary Completion

April 30, 2019

Study Completion

June 30, 2019

Last Updated

November 7, 2022

Record last verified: 2019-01

Locations